MLchartDataset catalogue

Polifeprosan 20 carmustine implant

Term · Oncology and biomedicine · MLC-T-ONC-006784

A drug used with surgery and radiation therapy to treat high-grade glioma that has not already been treated and with surgery to treat glioblastoma multiforme that has recurred (come back). Polifeprosan 20 carmustine implant is a form of carmustine contained in a wafer. The wafer has a coating that dissolves slowly and releases carmustine directly into the area where the brain tumor was removed. This form may have fewer side effects and work better than other forms of carmustine. Polifeprosan 20 carmustine implant is a type of alkylating agent and a type of nitrosourea. Also called carmustine implant and Gliadel Wafer.

Table 1. Record
IdentifierMLC-T-ONC-006784
FieldOncology and biomedicine
Synonymscarmustine implant; Gliadel Wafer
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-006784",
  "term": "Polifeprosan 20 carmustine implant",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with surgery and radiation therapy to treat high-grade glioma that has not already been treated and with surgery to treat glioblastoma multiforme that has recurred (come back). Polifeprosan 20 carmustine implant is a form of carmustine contained in a wafer. The wafer has a coating that dissolves slowly and releases carmustine directly into the area where the brain tumor was removed. This form may have fewer side effects and work better than other forms of carmustine. Polifeprosan 20 carmustine implant is a type of alkylating agent and a type of nitrosourea. Also called carmustine implant and Gliadel Wafer.",
  "synonyms": [
    "carmustine implant",
    "Gliadel Wafer"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/polifeprosan-20-carmustine-implant/"
}

Record 13,410 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.